Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Un-Audited Financial Results/Statements ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supha Pharmachem Ltd has informed BSE that its Board of Directors will meet on Saturday, 14 February 2026. The main agenda is to consider and approve the Un-Audited Financial Results (both Standalone and Consolidated) for the third quarter and nine months ended 31 December 2025. The trading window for insiders and designated persons has been closed since 1 January 2026 and will reopen 48 hours after the results are declared. The intimation is filed under SEBI LODR Regulation 29. The document carries no actual financial figures — it is only an advance notice of the upcoming results announcement.
This is a routine procedural filing with no immediate impact on shareholders. Investors should watch for the actual Q3 results on 14 February 2026, which could move the stock depending on revenue and profit performance versus prior periods.